Functional Medicine

Hypothyroidism: Very Common But Easily Missed

By Michael Traub, ND - Vol. 8, No. 4. Winter, 2007

Hypothyroidism is very common, and it has serious health consequences, including cardiovascular disease, obesity, menorrhagia, infertility, polycystic ovarian syndrome, depression, psoriasis, and urticaria. But you'll often miss it if you rely solely on conventional diagnostic criteria.

Digital Pulse Wave Analysis Offers Non-Invasive Early Heart Risk Assessment

By August West | Contributing Writer - Vol. 10, No. 2. Summer, 2009

Central Aortic Systolic Pressure (CASP) is one of the most powerful early predictors of cardiovascular risk. New digital pulse wave analysis technology is putting this valuable test in the hands of preventive primary care doctors.

A Role for Probiotics in Preventing, Treating Bacterial Vaginosis

By Brad J. Douglass, PhD | Contributing Writer - Vol. 10, No. 2. Summer, 2009

Say the word "probiotic" and people think, "gastrointestinal health." That's natural, since probiotics are invaluable in the management of digestive system problems. But they are also helpful for other health challenges, including infections of the female urogenital tract, like bacterial vaginosis, vulvovaginal candidiasis and related problems.

Functional Approaches to Pain Management: Highlights of the 15th Symposium on Functional Medicine

By Allison Templet | Contributing Writer - Vol. 10, No. 1. Spring, 2009

Pain is a highly individual experience, and therefore demands a personalized approach for its management. For each patient, various psychosocial, biomedical, and environmental factors converge to produce pain that is unique to that individual.

Oximation in Practice: Listen for the Fuse, Don't Wait for the Bomb

By Roby Mitchell, MD | Contributing Writer - Vol. 10, No. 1. Spring, 2009

Whether you're looking at arthritis or atherosclerosis, psoriasis or sinusitis, asthma or acne, the "usual suspects" of inflammation and oxidative damage, aka "oximation" show up in the affec

Some of the most important things I learned in medical school I learned from an oncologist, Dr. Phillip Perriman. He stressed the importance of keeping up with medical research by reading journals, and gave me my first exposure to the power of fruits and vegetables to influence cancer risk.

GGT: An Accurate, Inexpensive Predictor of Cardiometabolic Risk

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. Winter, 2008

Gamma glutamyl transferase (GGT) is a hepatic enzyme that indicates levels of oxidative stress in the liver. A large body of research suggests that it can also predict onset of insulin resistance, type 2 diabetes, and cardiovascular disease. At under $10 per test, it could be a very valuable asset in clinical practice.

IDA Medical Foundation Seeks to "Democratize" Prevention

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. Winter, 2008

Cutting edge early risk detection tests and preventive medicine have become the privilege of the wealthy. Dr. James Ehrlich, a pioneer in cardiovascular risk assessment, hopes to change that with his new Identify Disease in Advance Foundation, which will bring state-of-the-art preventive medicine to people who can least afford it but would most benefit from it.

Chronic Fatigue, Cardiomyopathy & Oxidative Stress: New Thinking Opens New Approaches

By Allison Templet | Contributing Writer - Vol. 9, No. 3. Fall, 2008

Chronic fatigue syndrome (CFS), one of the most vexing conditions for patients and doctors alike, reflects a state of oxygen toxicity, and management of oxidative stress appears to be a key to reversing the fatigue, pain, and neuropsychological complaints associated with this disorder, says Paul R. Cheney, MD, PhD, a pioneer in the clinical research of CFS.

Breast Thermography: Can It Open a Window for Breast Cancer Prevention?

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 3. Fall, 2008

Breast thermography is safe, radiation-free, relatively inexpensive, and it can detect early and possibly reversible metabolic and vascular changes associated with later growth of breast cancer. Though underutilized in the US, it is poised for a resurgence.